GoGo CoShea Whipped Shea Butta & Co.

07/25/2025

I told you if you CONTROL the INFLAMMATION in your body you CONTROL the DISEASE it’s just as simple as that!

Scientists find iron overload destroys microglia, worsening alzheimer’s and dementia through deadly cell death.

A groundbreaking new study has revealed a hidden culprit in Alzheimer’s disease and vascular dementia that could completely change how we tackle these devastating conditions. Researchers have discovered that microglia—the brain’s tiny immune cells that act like a cleanup crew—are being wiped out by a special kind of cell death called ferroptosis, which is caused by iron overload. This is huge because microglia are essential for keeping our brains healthy. They clear away damaged cells and debris, respond to injuries, and help keep brain wiring intact.

The problem starts when the protective myelin coating around nerve fibers breaks down. This myelin is loaded with iron, and as it crumbles, microglia rush in to clean up. But by absorbing all that iron-rich junk, they end up poisoning themselves. The study, led by scientists at Oregon Health & Science University, showed that this iron buildup triggers ferroptosis, causing microglia to die off. Without enough microglia, the brain loses a key line of defense, making it even more vulnerable to damage and cognitive decline.

These insights were made possible by innovative imaging techniques that highlighted iron’s toxic effects on microglia in brain tissue from Alzheimer’s and dementia patients. Researchers believe that blocking ferroptosis could protect microglia, slowing or even preventing brain deterioration. It’s a discovery that might finally give us a new angle on treating or delaying Alzheimer’s and vascular dementia—offering hope where little existed before.

RESEARCH PAPER 📄
PMID: 37605362
PMCID: PMC10840747

07/24/2025

A study found carnosic acid from sage and rosemary activated brain-protective NRF2 pathways, reversing Alzheimer's-like symptoms in mice. The compound crosses the blood-brain barrier, reducing inflammation and oxidative damage. While human trials are pending, this highlights nature's potential in neurodegenerative research. Always consult a doctor before using herbs therapeutically.
Disclaimer: This news is shared for journalistic and informational purposes only. Please consult your physician before making any medical decisions.

07/04/2025

Joe Tippens was given months to live. But after taking an anti-parasitic drug, PET scans revealed no detectable cancer cells. His cancer was gone.

In 2016, Tippens was diagnosed with terminal small-cell lung cancer and given a grim prognosis of mere months of survival. Desperate for alternatives, he began taking fenbendazole—a veterinary deworming medication typically used for dogs—in combination with supplements including Theracurmin (a concentrated turmeric extract) and CBD oil.

Remarkably, within three months of starting this unconventional protocol, his medical scans showed no trace of cancer. While it's impossible to definitively establish whether this dramatic recovery resulted from his self-directed treatment regimen, Tippens's extraordinary case rapidly gained attention throughout online patient communities, sparking widespread interest among both cancer patients and healthcare providers.

Emerging anecdotal evidence and preliminary laboratory studies now indicate that medications such as fenbendazole, mebendazole, and ivermectin may disrupt critical cancer cell processes including energy production, cellular division, and survival mechanisms. These compounds belong to the benzimidazole drug class and are both inexpensive and readily accessible, adding to their growing popularity.

Some integrative oncologists have started investigating these treatments with carefully selected patients, documenting instances of surprising cancer remissions. Nevertheless, none of these anti-parasitic medications have received FDA approval for cancer therapy, and rigorous clinical trials remain absent from the scientific literature.

Despite the compelling nature of these accounts and encouraging preliminary research findings, medical experts strongly advise that patients seek guidance from their healthcare providers.

07/03/2025

See ya Monday!

06/23/2025

🚨 SHOCKING STUDY: mRNA COVID-19 Vaccine Linked to Nearly 4x Higher Fetal Losses in Early Pregnancy, Israeli Data Reveals

Analysis of over 220K pregnancies in Israel during 2016- 2022 found that mRNA COVID-19 vaccination during gestational weeks 8-13 was associated with a higher-than-expected number of eventual fetal losses (miscarriages, abortions & stillbirths)!

Pregnant women vaccinated with dose 1 during weeks 8-13 had nearly 3.9 (95% CI: [2.55-5.14]) additional fetal losses above expected per 100 pregnancies. Most of the excess fetal losses occurred after gestational week 20 and nearly half occurred after gestational week 25.

In contrast, pregnant women vaccinated for influenza during weeks 8-27 exhibited a consistently lower-than-expected observed number of fetal losses, likely the result of healthy vaccinee bias. Women vaccinated for COVID-19 or influenza prior to pregnancy exhibited according-to-expected or lower-than-expected numbers of fetal losses.

The study used innovative observed-to-expected methodology, where data from prior years were leveraged to determine the expected number of fetal losses based on the individual characteristics of the pregnant women who vaccinated and their week of vaccination.